Skip to main content

Table 4 Results of Meta-analysis of medical cost

From: Clinical and economic outcomes of hospital pharmaceutical care: a systematic review and meta-analysis

Study | SMD [95% Conf. Interval] % Weight
Gallagher (2016) [33] |-2.2e+ 03 −4.7e+ 03 310.072 16.28
Shen (2011) [18] |-287.300 −439.475 − 135.125 28.23
Gums (1999) [10] | − 3.1e+ 03 -3.4e+ 03 −2.7e+ 03 27.83
Carter (1997) [8] |-420.000 − 868.487 28.487 27.66
D + L pooled WMD |-1.4e+ 03 −3.0e+ 03 155.203 100.00
  1. Heterogeneity chi-squared = 175.82 (d.f. = 3) p = 0.000.
  2. I-squared (variation in WMD attributable to heterogeneity) =98.3%.
  3. Estimate of between-study variance Tau-squared = 2.2e+ 06.
  4. Test of WMD = 0: z = 1.77 p = 0.078.
  5. The significance level of the combined effect quantity test: 0.05.
  6. The significance level of the heterogeneity test: 0.1.
  7. Heterogeneity test: p > 0.1, no heterogeneity was considered; p < 0.1, heterogeneity was considered.